Crosstalk between MUC1 and VEGF in angiogenesis and metastasis: a review highlighting roles of the MUC1 with an emphasis on metastatic and angiogenic signaling
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Crosstalk between MUC1 and VEGF in angiogenesis and metastasis: a review highlighting roles of the MUC1 with an emphasis on metastatic and angiogenic signaling
Authors
Keywords
-
Journal
Cancer Cell International
Volume 21, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-04-09
DOI
10.1186/s12935-021-01899-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- New proline, alanine, serine repeat sequence for pharmacokinetic enhancement of anti-VEGF single domain antibody
- (2020) Farnaz Khodabakhsh et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Crosstalk between MUC1 oncoprotein and ER, PR, and HER2 receptors in breast cancer cells
- (2018) N. Jalili et al. EUROPEAN JOURNAL OF CANCER
- Monoclonal antibody-based therapeutics, targeting the epidermal growth factor receptor family: from herceptin to Pan HER
- (2018) Shima Moradi-Kalbolandi et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Heterogeneity in VEGFR3 levels drives lymphatic vessel hyperplasia through cell-autonomous and non-cell-autonomous mechanisms
- (2018) Yan Zhang et al. Nature Communications
- A review on the role of VEGF in Tamoxifen resistance
- (2018) Sepideh Mansouri et al. Anti-Cancer Agents in Medicinal Chemistry
- Challenges facing antiangiogenesis therapy: The significant role of hypoxia-inducible factor and MET in development of resistance to anti-vascular endothelial growth factor-targeted therapies
- (2018) Ali Mahdi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Recruited bone marrow derived cells, local stromal cells and IL-17 at the front line of resistance development to anti-VEGF targeted therapies
- (2018) Behrad Darvishi et al. LIFE SCIENCES
- MUC1 induces tamoxifen resistance in estrogen receptor-positive breast cancer
- (2017) Parnaz Merikhian et al. Expert Review of Anticancer Therapy
- Metabolic Interactions in the Tumor Microenvironment
- (2017) Costas A. Lyssiotis et al. TRENDS IN CELL BIOLOGY
- Development of a novel nano-sized anti-VEGFA nanobody with enhanced physicochemical and pharmacokinetic properties
- (2017) Farnaz Khodabakhsh et al. Artificial Cells Nanomedicine and Biotechnology
- Role of tumor microenvironment in tumorigenesis
- (2017) Maonan Wang et al. Journal of Cancer
- Significant Role of MUC1 in Development of Resistance to Currently Existing Anti-cancer Therapeutic Agents
- (2017) Leila Farahmand et al. CURRENT CANCER DRUG TARGETS
- A novel association of neuropilin-1 and MUC1 in pancreatic ductal adenocarcinoma: role in induction of VEGF signaling and angiogenesis
- (2016) R Zhou et al. ONCOGENE
- Antitumor activity of a novel anti-vascular endothelial growth factor receptor-1 monoclonal antibody that does not interfere with ligand binding
- (2016) Grazia Graziani et al. Oncotarget
- Inhibition of VEGF165/VEGFR2-dependent signaling by LECT2 suppresses hepatocellular carcinoma angiogenesis
- (2016) Chi-Kuan Chen et al. Scientific Reports
- Overexpression of Vascular Endothelial Growth Factor A in Invasive Micropapillary Colorectal Carcinoma
- (2015) Marilin Rosa et al. Cancer Control
- Altered glycosylation of MUC1 influences its association with CIN85: the role of this novel complex in cancer cell invasion and migration
- (2015) Sandra Cascio et al. Oncotarget
- Expressions of MUC1 and vascular endothelial growth factor mRNA in blood are biomarkers for predicting efficacy of gefitinib treatment in non-small cell lung cancer
- (2014) Jian Li et al. BMC CANCER
- MUC1: a multifaceted oncoprotein with a key role in cancer progression
- (2014) Sritama Nath et al. TRENDS IN MOLECULAR MEDICINE
- Extracellular Matrix Modulates Angiogenesis in Physiological and Pathological Conditions
- (2014) Anna Neve et al. Biomed Research International
- Receptor Tyrosine Kinase-Mediated Angiogenesis
- (2013) M. Jeltsch et al. Cold Spring Harbor Perspectives in Biology
- MUC1 induces drug resistance in pancreatic cancer cells via upregulation of multidrug resistance genes
- (2013) S Nath et al. Oncogenesis
- Neuropilins: expression and roles in the epithelium
- (2012) Jonathan R. L. Wild et al. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
- MUC1 enhances hypoxia-driven angiogenesis through the regulation of multiple proangiogenic factors
- (2012) S Kitamoto et al. ONCOGENE
- MUC1 regulates PDGFA expression during pancreatic cancer progression
- (2012) M Sahraei et al. ONCOGENE
- MUC1-C oncoprotein as a target in breast cancer: activation of signaling pathways and therapeutic approaches
- (2012) D W Kufe ONCOGENE
- MUC1 mucin stabilizes and activates hypoxia-inducible factor 1 alpha to regulate metabolism in pancreatic cancer
- (2012) N. V. Chaika et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pancreatic Ductal Adenocarcinoma Mice Lacking Mucin 1 Have a Profound Defect in Tumor Growth and Metastasis
- (2011) D. M. Besmer et al. CANCER RESEARCH
- Basic and Therapeutic Aspects of Angiogenesis
- (2011) Michael Potente et al. CELL
- MUC1 Protein Expression in Tumor Cells Regulates Transcription of Proinflammatory Cytokines by Forming a Complex with Nuclear Factor-κB p65 and Binding to Cytokine Promoters
- (2011) Sandra Cascio et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Overexpression of MUC1 Enhances Proangiogenic Activity of Non-Small-Cell Lung Cancer Cells Through Activation of Akt and Extracellular Signal-regulated Kinase Pathways
- (2011) Mengying Yao et al. LUNG
- Mucin 1 C-Terminal Subunit Oncoprotein Is a Target for Small-Molecule Inhibitors
- (2011) Y. Zhou et al. MOLECULAR PHARMACOLOGY
- Mucin 1 enhances the tumor angiogenic response by activation of the AKT signaling pathway
- (2011) J K Woo et al. ONCOGENE
- MUC1-C Oncoprotein Promotes STAT3 Activation in an Autoinductive Regulatory Loop
- (2011) R. Ahmad et al. Science Signaling
- PI3K/AKT/mTOR Pathway in Angiogenesis
- (2011) Jayashree Karar et al. Frontiers in Molecular Neuroscience
- Growth Factor Mediated Signaling in Pancreatic Pathogenesis
- (2011) Debashis Nandy et al. Cancers
- Activated STAT3 is a mediator and biomarker of VEGF endothelial activation
- (2010) Shao-Hua Chen et al. CANCER BIOLOGY & THERAPY
- MUC1 regulates nuclear localization and function of the epidermal growth factor receptor
- (2010) B. G. Bitler et al. JOURNAL OF CELL SCIENCE
- The reactive tumor microenvironment: MUC1 signaling directly reprograms transcription of CTGF
- (2010) M E Behrens et al. ONCOGENE
- MUC1 enhances invasiveness of pancreatic cancer cells by inducing epithelial to mesenchymal transition
- (2010) L D Roy et al. ONCOGENE
- MUC1-C Oncoprotein Functions as a Direct Activator of the Nuclear Factor- B p65 Transcription Factor
- (2009) R. Ahmad et al. CANCER RESEARCH
- MUC1, a New Hypoxia Inducible Factor Target Gene, Is an Actor in Clear Renal Cell Carcinoma Tumor Progression
- (2009) S. Aubert et al. CANCER RESEARCH
- The basics of epithelial-mesenchymal transition
- (2009) Raghu Kalluri et al. JOURNAL OF CLINICAL INVESTIGATION
- The Role of Growth Factors and Cytokines during Implantation: Endocrine and Paracrine Interactions
- (2009) Ozlem Guzeloglu-Kayisli et al. SEMINARS IN REPRODUCTIVE MEDICINE
- Neuropilins: structure, function and role in disease
- (2008) Caroline Pellet-Many et al. BIOCHEMICAL JOURNAL
- The Cytoplasmic Tail of MUC1: A Very Busy Place
- (2008) D. D. Carson Science Signaling
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More